Preoperative Embolization of Skull Base Meningiomas: Outcomes in the Onyx Era

Preoperative embolization may facilitate skull base meningioma resection, but its safety and efficacy in the Onyx era have not been investigated. In this retrospective cohort study, we evaluated the outcomes of preoperative embolization of skull base meningiomas using Onyx as the primary embolysate....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World neurosurgery 2018-08, Vol.116, p.e371-e379
Hauptverfasser: Przybylowski, Colin J., Baranoski, Jacob F., See, Alfred P., Flores, Bruno C., Almefty, Rami O., Ding, Dale, Chapple, Kristina M., Sanai, Nader, Ducruet, Andrew F., Albuquerque, Felipe C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e379
container_issue
container_start_page e371
container_title World neurosurgery
container_volume 116
creator Przybylowski, Colin J.
Baranoski, Jacob F.
See, Alfred P.
Flores, Bruno C.
Almefty, Rami O.
Ding, Dale
Chapple, Kristina M.
Sanai, Nader
Ducruet, Andrew F.
Albuquerque, Felipe C.
description Preoperative embolization may facilitate skull base meningioma resection, but its safety and efficacy in the Onyx era have not been investigated. In this retrospective cohort study, we evaluated the outcomes of preoperative embolization of skull base meningiomas using Onyx as the primary embolysate. We queried an endovascular database for patients with skull base meningiomas who underwent preoperative embolization at our institution in 2007–2017. Patient, tumor, procedure, and outcome data were analyzed. Twenty-eight patients (28 meningiomas) underwent successful preoperative meningioma embolization. The mean patient age ± SD was 56 ± 13 years, and 18 patients (64%) were women. The mean tumor size was 49 cm3. There were 1, 2, or 3 arterial pedicles embolized in 21 cases (75%), 6 cases (21%), and 1 case (4%), respectively. The embolized pedicles included branches of the middle meningeal artery in 19 cases (68%), the internal maxillary artery in 8 cases (29%), the ascending pharyngeal artery in 2 cases (7%), and the posterior auricular, ophthalmic, occipital, and anterior cerebral arteries in 1 case each (4%). The embolysates used were Onyx alone in 20 cases (71%), n-butyl cyanoacrylate alone in 3 cases (11%), coils/particles and Onyx/n-butyl cyanoacrylate in 2 cases each (7%), and Onyx and coils in 1 case (4%). The median degree of tumor devascularization was 60%. Significant neurologic morbidity occurred in 1 patient (4%) who developed symptomatic peritumoral edema after Onyx embolization. For appropriately selected skull base meningiomas supplied by dura mater–based arterial pedicles without distal cranial nerve supply, preoperative embolization with current embolysate technology affords substantial tumor devascularization with a low complication rate. •Skull base meningioma embolization can be performed safely.•Onyx has favorable properties for skull base meningioma embolization.•The most serious risk of large skull base meningioma embolization is increased intracranial pressure.
doi_str_mv 10.1016/j.wneu.2018.04.208
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2038274623</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1878875018309288</els_id><sourcerecordid>2038274623</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-a17dd28551c452815907db5fafdc8cf519f3f322c9bc48f843a54206368a03553</originalsourceid><addsrcrecordid>eNp9kEtPwzAQhC0Eoqj0D3BAPnJp8SNOHMQFUHlIrYoEnC3XWYNLEhc7AcqvJ1VLj-xldqVvRtpB6ISSESU0PV-MvmpoR4xQOSJJp3IPHVGZyaHM0nx_twvSQ4MYF6QbThOZ8UPUY3kmKM3JEZo-BvBLCLpxn4DH1dyX7qc7fI29xU_vbVniax0BT6F29avzlY4XeNY2xlcQsatx8wZ4Vq--8TjoY3RgdRlhsNU-erkdP9_cDyezu4ebq8nQcJ41Q02zomBSCGoSwSQVOcmKubDaFkYaK2huueWMmXxuEmllwrVIGEl5KjXhQvA-OtvkLoP_aCE2qnLRQFnqGnwbFSNcsixJGe9QtkFN8DEGsGoZXKXDSlGi1k2qhVo3qdZNKpJ0KjvT6Ta_nVdQ7Cx_vXXA5QaA7stPB0FF46A2ULgAplGFd__l_wI5YYOK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2038274623</pqid></control><display><type>article</type><title>Preoperative Embolization of Skull Base Meningiomas: Outcomes in the Onyx Era</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Przybylowski, Colin J. ; Baranoski, Jacob F. ; See, Alfred P. ; Flores, Bruno C. ; Almefty, Rami O. ; Ding, Dale ; Chapple, Kristina M. ; Sanai, Nader ; Ducruet, Andrew F. ; Albuquerque, Felipe C.</creator><creatorcontrib>Przybylowski, Colin J. ; Baranoski, Jacob F. ; See, Alfred P. ; Flores, Bruno C. ; Almefty, Rami O. ; Ding, Dale ; Chapple, Kristina M. ; Sanai, Nader ; Ducruet, Andrew F. ; Albuquerque, Felipe C.</creatorcontrib><description>Preoperative embolization may facilitate skull base meningioma resection, but its safety and efficacy in the Onyx era have not been investigated. In this retrospective cohort study, we evaluated the outcomes of preoperative embolization of skull base meningiomas using Onyx as the primary embolysate. We queried an endovascular database for patients with skull base meningiomas who underwent preoperative embolization at our institution in 2007–2017. Patient, tumor, procedure, and outcome data were analyzed. Twenty-eight patients (28 meningiomas) underwent successful preoperative meningioma embolization. The mean patient age ± SD was 56 ± 13 years, and 18 patients (64%) were women. The mean tumor size was 49 cm3. There were 1, 2, or 3 arterial pedicles embolized in 21 cases (75%), 6 cases (21%), and 1 case (4%), respectively. The embolized pedicles included branches of the middle meningeal artery in 19 cases (68%), the internal maxillary artery in 8 cases (29%), the ascending pharyngeal artery in 2 cases (7%), and the posterior auricular, ophthalmic, occipital, and anterior cerebral arteries in 1 case each (4%). The embolysates used were Onyx alone in 20 cases (71%), n-butyl cyanoacrylate alone in 3 cases (11%), coils/particles and Onyx/n-butyl cyanoacrylate in 2 cases each (7%), and Onyx and coils in 1 case (4%). The median degree of tumor devascularization was 60%. Significant neurologic morbidity occurred in 1 patient (4%) who developed symptomatic peritumoral edema after Onyx embolization. For appropriately selected skull base meningiomas supplied by dura mater–based arterial pedicles without distal cranial nerve supply, preoperative embolization with current embolysate technology affords substantial tumor devascularization with a low complication rate. •Skull base meningioma embolization can be performed safely.•Onyx has favorable properties for skull base meningioma embolization.•The most serious risk of large skull base meningioma embolization is increased intracranial pressure.</description><identifier>ISSN: 1878-8750</identifier><identifier>EISSN: 1878-8769</identifier><identifier>DOI: 10.1016/j.wneu.2018.04.208</identifier><identifier>PMID: 29751190</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Devascularization ; Embolization ; Endovascular procedure ; Intracranial neoplasm ; Meningioma ; n-butyl cyanoacrylate (NBCA) ; Onyx ; Polyvinyl alcohol particles ; Skull base ; Tumor</subject><ispartof>World neurosurgery, 2018-08, Vol.116, p.e371-e379</ispartof><rights>2018 Elsevier Inc.</rights><rights>Copyright © 2018 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-a17dd28551c452815907db5fafdc8cf519f3f322c9bc48f843a54206368a03553</citedby><cites>FETCH-LOGICAL-c337t-a17dd28551c452815907db5fafdc8cf519f3f322c9bc48f843a54206368a03553</cites><orcidid>0000-0002-2627-446X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.wneu.2018.04.208$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29751190$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Przybylowski, Colin J.</creatorcontrib><creatorcontrib>Baranoski, Jacob F.</creatorcontrib><creatorcontrib>See, Alfred P.</creatorcontrib><creatorcontrib>Flores, Bruno C.</creatorcontrib><creatorcontrib>Almefty, Rami O.</creatorcontrib><creatorcontrib>Ding, Dale</creatorcontrib><creatorcontrib>Chapple, Kristina M.</creatorcontrib><creatorcontrib>Sanai, Nader</creatorcontrib><creatorcontrib>Ducruet, Andrew F.</creatorcontrib><creatorcontrib>Albuquerque, Felipe C.</creatorcontrib><title>Preoperative Embolization of Skull Base Meningiomas: Outcomes in the Onyx Era</title><title>World neurosurgery</title><addtitle>World Neurosurg</addtitle><description>Preoperative embolization may facilitate skull base meningioma resection, but its safety and efficacy in the Onyx era have not been investigated. In this retrospective cohort study, we evaluated the outcomes of preoperative embolization of skull base meningiomas using Onyx as the primary embolysate. We queried an endovascular database for patients with skull base meningiomas who underwent preoperative embolization at our institution in 2007–2017. Patient, tumor, procedure, and outcome data were analyzed. Twenty-eight patients (28 meningiomas) underwent successful preoperative meningioma embolization. The mean patient age ± SD was 56 ± 13 years, and 18 patients (64%) were women. The mean tumor size was 49 cm3. There were 1, 2, or 3 arterial pedicles embolized in 21 cases (75%), 6 cases (21%), and 1 case (4%), respectively. The embolized pedicles included branches of the middle meningeal artery in 19 cases (68%), the internal maxillary artery in 8 cases (29%), the ascending pharyngeal artery in 2 cases (7%), and the posterior auricular, ophthalmic, occipital, and anterior cerebral arteries in 1 case each (4%). The embolysates used were Onyx alone in 20 cases (71%), n-butyl cyanoacrylate alone in 3 cases (11%), coils/particles and Onyx/n-butyl cyanoacrylate in 2 cases each (7%), and Onyx and coils in 1 case (4%). The median degree of tumor devascularization was 60%. Significant neurologic morbidity occurred in 1 patient (4%) who developed symptomatic peritumoral edema after Onyx embolization. For appropriately selected skull base meningiomas supplied by dura mater–based arterial pedicles without distal cranial nerve supply, preoperative embolization with current embolysate technology affords substantial tumor devascularization with a low complication rate. •Skull base meningioma embolization can be performed safely.•Onyx has favorable properties for skull base meningioma embolization.•The most serious risk of large skull base meningioma embolization is increased intracranial pressure.</description><subject>Devascularization</subject><subject>Embolization</subject><subject>Endovascular procedure</subject><subject>Intracranial neoplasm</subject><subject>Meningioma</subject><subject>n-butyl cyanoacrylate (NBCA)</subject><subject>Onyx</subject><subject>Polyvinyl alcohol particles</subject><subject>Skull base</subject><subject>Tumor</subject><issn>1878-8750</issn><issn>1878-8769</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kEtPwzAQhC0Eoqj0D3BAPnJp8SNOHMQFUHlIrYoEnC3XWYNLEhc7AcqvJ1VLj-xldqVvRtpB6ISSESU0PV-MvmpoR4xQOSJJp3IPHVGZyaHM0nx_twvSQ4MYF6QbThOZ8UPUY3kmKM3JEZo-BvBLCLpxn4DH1dyX7qc7fI29xU_vbVniax0BT6F29avzlY4XeNY2xlcQsatx8wZ4Vq--8TjoY3RgdRlhsNU-erkdP9_cDyezu4ebq8nQcJ41Q02zomBSCGoSwSQVOcmKubDaFkYaK2huueWMmXxuEmllwrVIGEl5KjXhQvA-OtvkLoP_aCE2qnLRQFnqGnwbFSNcsixJGe9QtkFN8DEGsGoZXKXDSlGi1k2qhVo3qdZNKpJ0KjvT6Ta_nVdQ7Cx_vXXA5QaA7stPB0FF46A2ULgAplGFd__l_wI5YYOK</recordid><startdate>201808</startdate><enddate>201808</enddate><creator>Przybylowski, Colin J.</creator><creator>Baranoski, Jacob F.</creator><creator>See, Alfred P.</creator><creator>Flores, Bruno C.</creator><creator>Almefty, Rami O.</creator><creator>Ding, Dale</creator><creator>Chapple, Kristina M.</creator><creator>Sanai, Nader</creator><creator>Ducruet, Andrew F.</creator><creator>Albuquerque, Felipe C.</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2627-446X</orcidid></search><sort><creationdate>201808</creationdate><title>Preoperative Embolization of Skull Base Meningiomas: Outcomes in the Onyx Era</title><author>Przybylowski, Colin J. ; Baranoski, Jacob F. ; See, Alfred P. ; Flores, Bruno C. ; Almefty, Rami O. ; Ding, Dale ; Chapple, Kristina M. ; Sanai, Nader ; Ducruet, Andrew F. ; Albuquerque, Felipe C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-a17dd28551c452815907db5fafdc8cf519f3f322c9bc48f843a54206368a03553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Devascularization</topic><topic>Embolization</topic><topic>Endovascular procedure</topic><topic>Intracranial neoplasm</topic><topic>Meningioma</topic><topic>n-butyl cyanoacrylate (NBCA)</topic><topic>Onyx</topic><topic>Polyvinyl alcohol particles</topic><topic>Skull base</topic><topic>Tumor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Przybylowski, Colin J.</creatorcontrib><creatorcontrib>Baranoski, Jacob F.</creatorcontrib><creatorcontrib>See, Alfred P.</creatorcontrib><creatorcontrib>Flores, Bruno C.</creatorcontrib><creatorcontrib>Almefty, Rami O.</creatorcontrib><creatorcontrib>Ding, Dale</creatorcontrib><creatorcontrib>Chapple, Kristina M.</creatorcontrib><creatorcontrib>Sanai, Nader</creatorcontrib><creatorcontrib>Ducruet, Andrew F.</creatorcontrib><creatorcontrib>Albuquerque, Felipe C.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>World neurosurgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Przybylowski, Colin J.</au><au>Baranoski, Jacob F.</au><au>See, Alfred P.</au><au>Flores, Bruno C.</au><au>Almefty, Rami O.</au><au>Ding, Dale</au><au>Chapple, Kristina M.</au><au>Sanai, Nader</au><au>Ducruet, Andrew F.</au><au>Albuquerque, Felipe C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preoperative Embolization of Skull Base Meningiomas: Outcomes in the Onyx Era</atitle><jtitle>World neurosurgery</jtitle><addtitle>World Neurosurg</addtitle><date>2018-08</date><risdate>2018</risdate><volume>116</volume><spage>e371</spage><epage>e379</epage><pages>e371-e379</pages><issn>1878-8750</issn><eissn>1878-8769</eissn><abstract>Preoperative embolization may facilitate skull base meningioma resection, but its safety and efficacy in the Onyx era have not been investigated. In this retrospective cohort study, we evaluated the outcomes of preoperative embolization of skull base meningiomas using Onyx as the primary embolysate. We queried an endovascular database for patients with skull base meningiomas who underwent preoperative embolization at our institution in 2007–2017. Patient, tumor, procedure, and outcome data were analyzed. Twenty-eight patients (28 meningiomas) underwent successful preoperative meningioma embolization. The mean patient age ± SD was 56 ± 13 years, and 18 patients (64%) were women. The mean tumor size was 49 cm3. There were 1, 2, or 3 arterial pedicles embolized in 21 cases (75%), 6 cases (21%), and 1 case (4%), respectively. The embolized pedicles included branches of the middle meningeal artery in 19 cases (68%), the internal maxillary artery in 8 cases (29%), the ascending pharyngeal artery in 2 cases (7%), and the posterior auricular, ophthalmic, occipital, and anterior cerebral arteries in 1 case each (4%). The embolysates used were Onyx alone in 20 cases (71%), n-butyl cyanoacrylate alone in 3 cases (11%), coils/particles and Onyx/n-butyl cyanoacrylate in 2 cases each (7%), and Onyx and coils in 1 case (4%). The median degree of tumor devascularization was 60%. Significant neurologic morbidity occurred in 1 patient (4%) who developed symptomatic peritumoral edema after Onyx embolization. For appropriately selected skull base meningiomas supplied by dura mater–based arterial pedicles without distal cranial nerve supply, preoperative embolization with current embolysate technology affords substantial tumor devascularization with a low complication rate. •Skull base meningioma embolization can be performed safely.•Onyx has favorable properties for skull base meningioma embolization.•The most serious risk of large skull base meningioma embolization is increased intracranial pressure.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29751190</pmid><doi>10.1016/j.wneu.2018.04.208</doi><orcidid>https://orcid.org/0000-0002-2627-446X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1878-8750
ispartof World neurosurgery, 2018-08, Vol.116, p.e371-e379
issn 1878-8750
1878-8769
language eng
recordid cdi_proquest_miscellaneous_2038274623
source Elsevier ScienceDirect Journals Complete
subjects Devascularization
Embolization
Endovascular procedure
Intracranial neoplasm
Meningioma
n-butyl cyanoacrylate (NBCA)
Onyx
Polyvinyl alcohol particles
Skull base
Tumor
title Preoperative Embolization of Skull Base Meningiomas: Outcomes in the Onyx Era
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A36%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preoperative%20Embolization%20of%20Skull%20Base%20Meningiomas:%20Outcomes%20in%20the%20Onyx%20Era&rft.jtitle=World%20neurosurgery&rft.au=Przybylowski,%20Colin%20J.&rft.date=2018-08&rft.volume=116&rft.spage=e371&rft.epage=e379&rft.pages=e371-e379&rft.issn=1878-8750&rft.eissn=1878-8769&rft_id=info:doi/10.1016/j.wneu.2018.04.208&rft_dat=%3Cproquest_cross%3E2038274623%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2038274623&rft_id=info:pmid/29751190&rft_els_id=S1878875018309288&rfr_iscdi=true